Board of Directors

David Chu, CEO

David Chu, our Chief Executive Officer, is a highly regarded entrepreneur, business builder, designer, and creative executive in the global consumer sector, with extensive experience in brand development and repositioning. Mr. Chu was the founder and Chief Executive Officer of Nautica, and between 1983 and 2003 he led its expansion into a global lifestyle brand with a distribution and license portfolio spanning 100 countries. Starting with outerwear, Mr. Chu led Nautica’s category expansion into sportswear, activewear, womenswear and childrenswear. He also strategically extended the Nautica product line by augmenting centralized brand management with tightly controlled license agreements, adding fragrances, tailored clothing, dress shirts and accessories. In 2003, Nautica was sold to VF Corporation. Between 2007 and 2009, Mr. Chu was the Executive Creative Director and a board member of Tumi. During his time at Tumi, Mr. Chu successfully repositioned the brand from high quality, functional luggage to a premium lifestyle brand for men and women. In 2012, Mr. Chu joined Georg Jensen A/S, where he served as the Chief Executive Officer, Chief Creative Officer and chairman of the board; Mr. Chu is currently still a member of the board.

Donald Tang, President

Donald Tang, our President, has extensive experience as a private equity investor. In 2018, he founded Celadon Partners (Asia Pacific) Limited, or Celadon Partners, a private equity firm focused on mispriced opportunities ready for operational or strategic transformation, with an emphasis on the consumer space. From 2004 to 2017, Mr. Tang worked at D.E. Shaw & Co., most recently as Chief Executive Officer of D.E. Shaw & Co. (Asia-Pacific). He was the sole D.E. Shaw & Co. partner on the investment side in Asia, and a founding member of the firm’s Asian private equity business. Mr. Tang started his career at Citadel Investment Group in 2003. He is a member of the Harvard Kennedy School Mossavar-Rahmani Center for Business and Government Advisory Council, Special Advisor (China) to the Milken Institute and a member of the Aspen Global Leadership Network. Donald graduated from Carnegie Mellon University with a degree in computer science and business administration, and a minor in computational finance.

Dr. David D. Ho, Independent Director

David D. Ho is the Founding Scientific Director of the Aaron Diamond AIDS Research Center and the Clyde and Helen Wu Professor of Medicine at Columbia University Irving Medical Center. He received his degrees from California Institute of Technology and Harvard Medical School. Dr. Ho has been at the forefront of AIDS research for 40 years. His elegant studies unraveled the dynamic nature of HIV replication in vivo and revolutionized our basic understanding of this horrific disease. This knowledge led him to champion combination antiretroviral therapy that resulted in unprecedented control of HIV in patients. An automatic death sentence has been transformed into a manageable disease, and over 25 million worldwide are currently on such therapy. Dr. Ho’s research team is now devoting a considerable effort to develop novel strategies to diagnose, treat and prevent Covid-19 infection.

Dr. Ho has received fourteen honorary doctorates. He was named Time Magazine’s Man of the Year in 1996 and the recipient of a Presidential Medal from Bill Clinton in 2001. He was also inducted into the California Hall of Fame. Dr. Ho was also recognized by the Kingdom of Thailand with the Prince Mahidol Award in Medicine, and given the Distinguished Alumni Award by Caltech. Dr. Ho serves as a member of the Trustees of Caltech, and was a board member of the MIT Corporation for 12 years and Harvard Board of Overseers for 6 years. He is a member of the US National Academy of Medicine as well as the Chinese Academy of Engineering.

Michael Kives, Independent Director

Michael Kives is the founder and CEO of K5 Global, an advisory and investment firm - with clients including Creative Artists Agency, TPG, and Sequoia China - and investments including SpaceX, the Boring Company, and Catalyte. Prior to founding K5, he was an Agent at Creative Artists Agency for 15 years, where he represented a wide range of talent, including Bruce Willis, Arnold Schwarzenegger, Katy Perry, Kate Hudson, Jessica Alba, as well as world and business leaders, Mikhail Gorbachev and Warren Buffett. Prior to joining CAA in 2003, Mr. Kives worked in the Harlem office of President William J. Clinton, where he served as an interim spokesperson for the President. He then transitioned to Senator Hillary Rodham Clinton’s D.C. office, where he worked alongside Chief of Staff, Huma Abedin. Additionally, he serves on the Board of Directors of Cirque du Soleil and Shutterfly.

Mr. Kives graduated Phi Beta Kappa with Distinction from Stanford University.

Fred Langhammer, Independent Director

Fred H. Langhammer is Chairman, Global Affairs, of The Estee Lauder Companies Inc., a manufacturer and marketer of cosmetics products. Prior to being named Chairman, Global Affairs, Mr. Langhammer was Chief Executive Officer of The Estee Lauder Companies Inc. from 2000 to 2004, President from 1995 to 2004 and Chief Operating Officer from 1985 through 1999. Mr. Langhammer joined The Estee Lauder Companies in 1975 as President of its operations in Japan. In 1982, he was appointed Managing Director of its operations in Germany.

He was a director of Central European Media Enterprises, Ltd. from December 2009 through March 2014, a director of The Shinsei Bank Limited from 2005 to 2009, a director of AIG from 2006 to 2008 and a director of the Walt Disney Company from 2005 until 2019. He also serves as Chairman Emeritus of the American Institute for Contemporary German Studies at Johns Hopkins University and is a senior fellow of the Foreign Policy Association. Mr. Langhammer holds dual citizenship for U.S.A. and Germany. Educated in Germany, Canada and Japan, he speaks fluent Japanese and German. He is also a recipient of the Commander's Cross of the Order of Merit of the Federal Republic of Germany.

Terry Lundgren, Independent Director

Terry Lundgren served for 14 years as CEO of Macy’s, Inc., operator of Macy’s, Bloomingdale’s, Bluemercury and one of the largest retail ecommerce businesses in America. He retired from Macy’s, Inc. in January 2018 after serving for 10 months as the company’s Executive Chairman. Prior to becoming CEO of the company in February 2003 and Chairman and CEO in January 2004, Lundgren had been President and Chief Merchandising Officer since May 1997 (the company’s name changed to Macy’s, Inc. from Federated Department Stores, Inc. in 2007). Mr. Lundgren joined Neiman Marcus in 1988 as Executive Vice President and shortly thereafter was named Chairman and CEO. He held that position until 1994 when he returned to Federated as Chairman and CEO of the Federated Merchandising Group. As CEO of the corporation, Lundgren led Federated’s acquisition of The May Department Stores Company in August 2005, nearly doubling the size of the company.

Mr. Lundgren currently serves on the boards of The Procter & Gamble Company, Carnegie Hall and the Economic Club of New York. He is also a former board member of Kraft Foods Inc., the Federal Reserve Bank of New York and Chairman of the National Retail Federation (twice). He also currently serves as an Executive In Residence at Columbia Business School.


Bryan Baum

Bryan Baum co-founded Panoramic, an enterprise SaaS company that connects data, systems, and people together in a single marketing intelligence platform to collectively solve marketing challenges. Panoramic raised $35 million in funding from TPG (Affinity), Anchorage Capital, MGM, and others. Baum also founded Operam in 2016, an AI-powered marketing intelligence platform. Operam has over 100 employees and works with Fox, Amazon, Sweetgreen, FabFitFun, Sony and others. In 2016, Mr. Baum founded Blue Vision Labs, a cloud-based computer vision company that allows for collaborative Augmented Reality. BVL raised $17.5 million from Google Ventures, Accel, and Horizons Ventures, and sold to Lyft in 2018 for $102 million. In 2014, he founded, which allows anyone to create and sell their own custom merchandise online with no upfront cost or risk. Represent sold custom apparel to over 2 million customers. It was purchased by CustomInk in 2016 for $100 million. Before Represent he founded, which sold in 2014 to Chideo. Mr. Baum is also an active angel investor and has invested in early rounds of companies including: Uber, Airbnb, Juul, PillPack, LendingHome, Flexport, Sweetgreen, and others.

Mr. Baum is also an angel investor on the Board of Directors of the Drug Enforcement Agency (DEA) Foundation, was named a Technology Pioneer by the World Economic Forum in 2018 and studied Game Theory at Swarthmore (PA), and Oxford University (UK).

Dr. Tomoaki Kato

Tomoaki Kato, M.D., is a noted pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Dr. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons.

Dr. Kato is known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT (auxiliary partial orthotopic liver transplantation) that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor.

Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Dr. Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital (previously Cedars Medical Center), beginning in 2004. Dr. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals.

James Lee

James Lee is a Fellow at the Wharton School and noted speaker on branding, design and innovation. He has been a major contributor to the Danish fashion industry and New Nordic food movement as a founder, investor and board member of various enterprises that have spearheaded the region’s global cultural footprint. At 23, he was recognized by Index, the world’s largest design prize as being amongst the top 20 Creative Leaders in the world. He has also founded award winning advertising agency, brand consultancy and design companies that have led the creative direction, international business development, and retail & marketing strategies for multinationals such as Samsung, LG, Li & Fung, Bang & Olufsen and Georg Jensen, among others.